CoChat

In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes

Open access
Tascher, Georg, Burban, Audrey, Camus, Sandrine, Plumel, Marine, Chanon, Stéphanie, Le Guevel, Remy, Shevchenko, Valery, Van Dorsselaer, Alain, Lefai, Etienne, Guguen-Guillouzo, Christiane, Bertile, Fabrice · 2019 · Cells
Cited by 75

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Of the hepatic cell lines developed for in vitro studies of hepatic functions as alternatives to primary human hepatocytes, many have lost major liver-like functions, but not HepaRG cells. The increasing use of the latter worldwide raises the need for establishing the reference functional status of early biobanked HepaRG cells. Using deep proteome and secretome analyses, the levels of master regulators of the hepatic phenotype and of the structural elements ensuring biliary polarity were found to be close to those in primary hepatocytes. HepaRG cells proved to be highly differentiated, with functional mitochondria, hepatokine secretion abilities, and an adequate response to insulin. Among differences between primary human hepatocytes and HepaRG cells, the factors that possibly support HepaRG transdifferentiation properties are discussed. The HepaRG cell system thus appears as a robust surrogate for primary hepatocytes, which is versatile enough to study not only xenobiotic detoxification, but also the control of hepatic energy metabolism, secretory function and disease-related mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8020192

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 54

  1. Nagaki, 2008, Transcription factor HNF and hepatocyte differentiation, Hepatol Res., 38, 961, 10.1111/j.1872-034X.2008.00367.x · DOI
  2. Guillouzo, 2010, General review on in vitro hepatocyte models and their applications, Methods Mol. Biol., 640, 1, 10.1007/978-1-60761-688-7_1 · DOI · Paper page
  3. Godoy, 2016, Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue, Arch. Toxicol., 90, 2513, 10.1007/s00204-016-1761-4 · DOI · Paper page
  4. Vildhede, 2015, Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure, J. Proteome Res., 14, 3305, 10.1021/acs.jproteome.5b00334 · DOI · Paper page
  5. Rogue, 2012, Interindividual variability in gene expression profiles in human hepatocytes and comparison with HepaRG cells, Drug Metab. Dispos., 40, 151, 10.1124/dmd.111.042028 · DOI
  6. Andersson, 2012, The HepaRG cell line: A unique in vitro tool for understanding drug metabolism and toxicology in human, Expert Opin. Drug Metab. Toxicol., 8, 909, 10.1517/17425255.2012.685159 · DOI · Paper page
  7. Cerec, 2007, Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, 45, 957, 10.1002/hep.21536 · DOI · Paper page
  8. Smith, 2018, Differential impacts of individual and combined exposures of deoxynivalenol and zearalenone on the HepaRG human hepatic cell proteome, J. Proteom., 173, 89, 10.1016/j.jprot.2017.11.025 · DOI
  9. Gripon, 2002, Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci. USA, 99, 15655, 10.1073/pnas.232137699 · DOI · Paper page
  10. Wisniewski, 2014, Multi-enzyme digestion FASP and the ‘Total Protein Approach’-based absolute quantification of the Escherichia coli proteome, J. Proteom., 109, 322, 10.1016/j.jprot.2014.07.012 · DOI · Paper page
  11. Klein, 2014, Long-term maintenance of HepaRG cells in serum-free conditions and application in a repeated dose study, J. Appl. Toxicol., 34, 1078, 10.1002/jat.2929 · DOI · Paper page
  12. Plumel, 2016, Differential proteomics reveals age-dependent liver oxidative costs of innate immune activation in mice, J. Proteom., 135, 181, 10.1016/j.jprot.2015.09.008 · DOI
  13. Cox, 2011, Andromeda: A peptide search engine integrated into the MaxQuant environment, J Proteome Res., 10, 1794, 10.1021/pr101065j · DOI · Paper page
  14. Carapito, 2014, MSDA, a proteomics software suite for in-depth Mass Spectrometry Data Analysis using grid computing, Proteomics, 14, 1014, 10.1002/pmic.201300415 · DOI
  15. Vizcaino, 2016, 2016 update of the PRIDE database and its related tools, Nucleic Acids Res., 44, D447, 10.1093/nar/gkv1145 · DOI · Paper page
  16. Chawade, 2014, Normalyzer: A tool for rapid evaluation of normalization methods for omics data sets, J Proteome Res., 13, 3114, 10.1021/pr401264n · DOI · Paper page
  17. Duncan, 2013, Aneuploidy, polyploidy and ploidy reversal in the liver, Semin. Cell Dev. Biol., 24, 347, 10.1016/j.semcdb.2013.01.003 · DOI · Paper page
  18. Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
  19. Cox, J., and Mann, M. (2012). 1D and 2D annotation enrichment: A statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinform., 13. · DOI · Paper page
  20. Pham, 2010, On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics, Bioinformatics, 26, 363, 10.1093/bioinformatics/btp677 · DOI · Paper page
  21. Jackson, 2016, Contextualizing Hepatocyte Functionality of Cryopreserved HepaRG Cell Cultures, Drug Metab. Dispos., 44, 1463, 10.1124/dmd.116.069831 · DOI
  22. Knowles, 1980, Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen, Science, 209, 497, 10.1126/science.6248960 · DOI · Paper page
  23. Cheung, 2009, Hep G2 is a hepatoblastoma-derived cell line, Hum. Pathol., 40, 1512, 10.1016/j.humpath.2009.07.003 · DOI · Paper page
  24. Gissen, 2015, Structural and functional hepatocyte polarity and liver disease, J. Hepatol., 63, 1023, 10.1016/j.jhep.2015.06.015 · DOI · Paper page
  25. Sharanek, 2016, Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, Sci. Rep., 6, 24709, 10.1038/srep24709 · DOI · Paper page
  26. Yang, 2012, Cooperative activation of PI3K by Ras and Rho family small GTPases, Mol. Cell, 47, 281, 10.1016/j.molcel.2012.05.007 · DOI · Paper page
  27. Thenappan, 2010, Role of transforming growth factor beta signaling and expansion of progenitor cells in regenerating liver, Hepatology, 51, 1373, 10.1002/hep.23449 · DOI
  28. Guillemot, 2012, Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury, J. Cell Sci., 125, 5005
  29. Gunaratne, 2009, Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors, Hum. Pathol., 40, 783, 10.1016/j.humpath.2008.07.022 · DOI · Paper page
  30. Torre, 2011, Transcription dynamics in a physiological process: Beta-catenin signaling directs liver metabolic zonation, Int. J. Biochem. Cell Biol., 43, 271, 10.1016/j.biocel.2009.11.004 · DOI
  31. Hoekstra, 2011, The HepaRG cell line is suitable for bioartificial liver application, Int. J. Biochem. Cell Biol., 43, 1483, 10.1016/j.biocel.2011.06.011 · DOI
  32. Moedas, 2017, Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS, Anal. Biochem., 535, 47, 10.1016/j.ab.2017.07.025 · DOI
  33. Pernelle, 2011, Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye, Toxicol. Appl. Pharm., 254, 256, 10.1016/j.taap.2011.04.018 · DOI
  34. Xu, 2005, Induction of phase I, II and III drug metabolism/transport by xenobiotics, Arch. Pharm. Res., 28, 249, 10.1007/BF02977789 · DOI · Paper page
  35. Aninat, 2006, Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells, Drug Metab. Dispos., 34, 75, 10.1124/dmd.105.006759 · DOI · Paper page
  36. Wigger, L., Casals-Casas, C., Baruchet, M., Trang, K., Pradervand, S., Naldi, A., and Desvergne, B. (2019). System analysis of the functional cross-talk between PPARalpha, LXR and FXR in the human HepaRG liver cells. bioRxiv, 514976.
  37. Kanebratt, 2008, Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies, Drug Metab. Dispos., 36, 1444, 10.1124/dmd.107.020016 · DOI · Paper page
  38. Attignon, 2017, Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells, Arch. Toxicol., 91, 313, 10.1007/s00204-016-1700-4 · DOI
  39. Sarsour, 2014, Manganese superoxide dismutase regulates a redox cycle within the cell cycle, Antioxid. Redox Signal., 20, 1618, 10.1089/ars.2013.5303 · DOI
  40. Hu, 2014, Keap1 modulates the redox cycle and hepatocyte cell cycle in regenerating liver, Cell Cycle, 13, 2349, 10.4161/cc.29298 · DOI
  41. Gilot, 2002, Liver protection from apoptosis requires both blockage of initiator caspase activities and inhibition of ASK1/JNK pathway via glutathione S-transferase regulation, J. Biol. Chem., 277, 49220, 10.1074/jbc.M207325200 · DOI
  42. Burban, 2017, Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC/P38 and PI3K/AKT signaling pathways, Sci. Rep., 7, 1815, 10.1038/s41598-017-01171-y · DOI
  43. Madec, 2011, CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload, Drug Metab. Dispos., 39, 1987, 10.1124/dmd.110.036848 · DOI
  44. Samanez, 2012, The human hepatocyte cell lines IHH and HepaRG: Models to study glucose, lipid and lipoprotein metabolism, Arch. Physiol. Biochem., 118, 102, 10.3109/13813455.2012.683442 · DOI · Paper page
  45. Hijmans, 2014, Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences, Biochimie, 96, 121, 10.1016/j.biochi.2013.06.007 · DOI · Paper page
  46. Hall, 2014, USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy, Mol. Endocrinol., 28, 912, 10.1210/me.2013-1420 · DOI · Paper page
  47. Adachi, 2007, The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells, Gastroenterology, 132, 1434, 10.1053/j.gastro.2007.01.033 · DOI
  48. Parent, 2007, Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth, Cancer Res., 67, 4337, 10.1158/0008-5472.CAN-06-3640 · DOI
  49. Agrawal, 2014, DEPTOR is a stemness factor that regulates pluripotency of embryonic stem cells, J. Biol. Chem., 289, 31818, 10.1074/jbc.M114.565838 · DOI
  50. Ou, 2012, Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance, Endocrinology, 153, 2974, 10.1210/en.2011-2043 · DOI · Paper page
  51. Wagner, M., and Trauner, M. (2016). Recent advances in understanding and managing cholestasis. F1000Res, 5. · DOI
  52. Yang, 2010, Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice, Hepatology, 51, 1291, 10.1002/hep.23471 · DOI
  53. Sharanek, 2014, Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells, Toxicol. Sci., 141, 244, 10.1093/toxsci/kfu122 · DOI
  54. Dessalle, K., Euthine, V., Chanon, S., Delarichaudy, J., Fujii, I., Rome, S., Vidal, H., Nemoz, G., Simon, C., and Lefai, E. (2012). SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors. PLoS One, 7. · DOI · Paper page

Cited by

Metadata

Authors
Tascher, G., Burban, A., Camus, S., Plumel, M., Chanon, S., Le Guevel, R., Shevchenko, V., Van Dorsselaer, A., Lefai, E., Guguen-Guillouzo, C., & Bertile, F.
Venue
Cells
Publisher
MDPI AG
Published
2019-02-21
Volume
8
Issue
2
Pages
192
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2916303558
Cited by
75
References
9
FWCI
4.61
Type
journal article
Language
en
Open access
gold
Funders
  • Seventh Framework Programme (267038)
  • Cosmetics Europe (267038)
  • French Proteomic Infrastructure (ProFI) (ANR-10-INSB-08-03)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.